BioSpace News Archive

ViroCell Biologics, a specialist contract development and manufacturing organisation in cell and gene therapy clinical trials, announces the appointment of Traci Kyes as Vice President of Business Development and Makis Sigalas as Senior Business Development Director.

EVONETIX LTD, the Company developing semiconductor scale technology to improve access to gene synthesis, announced its first placement of a DNA synthesis development platform for evaluation at Imperial College London.

Sandoz, the global leader in generic and biosimilar medicines, celebrates the start of share trading on the SIX Swiss Exchange as an independent company.

Orakl Oncology, a precision oncology start-up, announces that it has raised €3 million to develop its techbio platform that integrates best-in-class biology with real-world patient data at scale to accurately model tumors and accelerate oncology drug development.

Sanofi and Teva Pharmaceuticals, a U.S. subsidiary of Teva Pharmaceutical Industries Ltd. announce a collaboration to co-develop and co-commercialize asset TEV ‘574, currently in Phase 2b clinical trials for the treatment of Ulcerative Colitis and Crohn’s Disease, two types of inflammatory bowel disease.

Scalp cooling innovator Dignitana AB announces a sales and marketing partnership with InfuSystem Holdings, Inc., a leading health care service provider facilitating outpatient care for durable medical equipment manufacturers and health care providers in the United States.

Elixir Medical, a developer of disruptive cardiovascular technologies, announced submission to Japan’s Pharmaceutical and Medical Device Agency for the approval of the DynamX® Coronary Bioadaptor System for the treatment of coronary artery disease.

Oncoinvent AS announced the presentation of preliminary 18-month safety and efficacy data from its ongoing Phase 1/2A clinical trial evaluating the safety, tolerability, and signal of efficacy of Radspherin® in patients with peritoneal carcinomatosis from colorectal cancer at the 13th International Congress on Peritoneal Surface Malignancies of the Peritoneal Surface Oncology Group International, to be held at the Palazzo del Cinema in Venice, Italy from October 4 - 6, 2023.

Skanska has signed an additional contract with RWJBarnabas Health to build an ambulatory care cancer center in Livingston, New Jersey, USA.

Synthego, a leading provider of genome engineering solutions, announced the launch of its IND-enabling gRNAs, a transformative product offering that revolutionizes the CRISPR-based cell and gene therapy preclinical pipeline.